These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26502971)

  • 21. Fight INflammation to Improve outcome after aneurysmal Subarachnoid HEmorRhage (FINISHER) trial: Study protocol for a randomized controlled trial.
    Güresir E; Lampmann T; Bele S; Czabanka M; Czorlich P; Gempt J; Goldbrunner R; Hurth H; Hermann E; Jabbarli R; Krauthausen M; König R; Lindner D; Malinova V; Meixensberger J; Mielke D; Németh R; Darkwah Oppong M; Pala A; Prinz V; Rashidi A; Roder C; Sandalcioglu IE; Sauvigny T; Schebesch KM; Timmer M; Vajkoczy P; Wessels L; Wild F; Wilhelm C; Wostrack M; Vatter H; Coch C
    Int J Stroke; 2023 Feb; 18(2):242-247. PubMed ID: 35361026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Circulating Lactate and Glucose Levels After Aneurysmal Subarachnoid Hemorrhage Correlate With Poor Outcome and Delayed Cerebral Ischemia: A Two-Center Cohort Study.
    van Donkelaar CE; Dijkland SA; van den Bergh WM; Bakker J; Dippel DW; Nijsten MW; van der Jagt M
    Crit Care Med; 2016 May; 44(5):966-72. PubMed ID: 26751612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials.
    Ma L; Liu WG; Zhang JM; Chen G; Fan J; Sheng HS
    Brain Inj; 2010; 24(5):730-5. PubMed ID: 20334471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage.
    Woo PYM; Ho JWK; Ko NMW; Li RPT; Jian L; Chu ACH; Kwan MCL; Chan Y; Wong AKS; Wong HT; Chan KY; Kwok JCK
    BMC Neurol; 2020 Nov; 20(1):401. PubMed ID: 33143640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
    Liu H; Xu X
    Am J Emerg Med; 2017 Dec; 35(12):1940-1945. PubMed ID: 28966073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.
    Takeuchi S; Mori K; Arimoto H; Fujii K; Nagatani K; Tomura S; Otani N; Osada H; Wada K
    BMC Neurol; 2014 Sep; 14():176. PubMed ID: 25201463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage.
    Kruyt ND; Roos YW; Dorhout Mees SM; van den Bergh WM; Algra A; Rinkel GJ; Biessels GJ
    J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1382-5. PubMed ID: 18403438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
    Shaw MD; Vermeulen M; Murray GD; Pickard JD; Bell BA; Teasdale GM
    J Neurosurg; 2000 Dec; 93(6):992-7. PubMed ID: 11117873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis.
    Wong GK; Boet R; Poon WS; Chan MT; Gin T; Ng SC; Zee BC
    Crit Care; 2011; 15(1):R52. PubMed ID: 21299874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage.
    Darkwah Oppong M; Gembruch O; Pierscianek D; Köhrmann M; Kleinschnitz C; Deuschl C; Mönninghoff C; Kaier K; Forsting M; Sure U; Jabbarli R
    Neurosurgery; 2019 Dec; 85(6):827-833. PubMed ID: 30544176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spreading depolarization-modulating drugs and delayed cerebral ischemia after subarachnoid hemorrhage: A hypothesis-generating retrospective clinical study.
    Hamming AM; Mulder IA; Gathier CS; van den Bergh WM; Dankbaar JW; Hoff RG; Vandertop WP; Verbaan D; Ferrari MD; Rinkel GJE; Algra A; Wermer MJH
    J Neurol Sci; 2016 Jul; 366():224-228. PubMed ID: 27288811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage.
    Ma C; Zhou W; Yan Z; Qu M; Bu X
    J Neurol Sci; 2015 Dec; 359(1-2):67-71. PubMed ID: 26671088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced Hypertension in Preventing Cerebral Infarction in Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.
    Haegens NM; Gathier CS; Horn J; Coert BA; Verbaan D; van den Bergh WM
    Stroke; 2018 Nov; 49(11):2630-2636. PubMed ID: 30355184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Spreading Depolarization and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Post Hoc Analysis of a Randomized Trial of the Effect of Cilostazol on Delayed Cerebral Ischemia.
    Kawano A; Sugimoto K; Nomura S; Inoue T; Kawano R; Oka F; Sadahiro H; Ishihara H; Suzuki M
    Neurocrit Care; 2021 Oct; 35(Suppl 2):91-99. PubMed ID: 34462881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
    Vergouwen MD; de Haan RJ; Vermeulen M; Roos YB
    Stroke; 2010 Jan; 41(1):e47-52. PubMed ID: 19875741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality.
    Kerz T; Victor A; Beyer C; Trapp I; Heid F; Reisch R
    Neurol Res; 2008 Nov; 30(9):893-7. PubMed ID: 18691455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage.
    Takeuchi S; Kumagai K; Toyooka T; Otani N; Wada K; Mori K
    Stroke; 2021 Jan; 52(1):20-27. PubMed ID: 33349011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnesium sulphate for aneurysmal subarachnoid hemorrhage: why, how, and current controversy.
    Wong GK; Poon WS
    Acta Neurochir Suppl; 2013; 115():45-8. PubMed ID: 22890642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FIVHeMA: Intraventricular fibrinolysis versus external ventricular drainage alone in aneurysmal subarachnoid hemorrhage: A randomized controlled trial.
    Gaberel T; Gakuba C; Fournel F; Le Blanc E; Gaillard C; Peyro-Saint-Paul L; Chaillot F; Tanguy P; Parienti JJ; Emery E
    Neurochirurgie; 2019 Feb; 65(1):14-19. PubMed ID: 30638547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.